LGALS1 and malignant colon neoplasm: Galectin-1 appears to be consistently elevated throughout the progression of colon cancer with increases observed in stages I–IV (p < 0.0001, p < 0.0022, p < 0.0026, p < 0.0014, respectively) (Figure 2B).